Shandong Sino-Agri United Biotechnology Co.,Ltd (SHE:003042)
China · Delayed Price · Currency is CNY 17.09
+0.20 (1.18%)
Apr 30, 2026, 3:04 PM CST
SHE:003042 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,861 | 2,011 | 1,673 | 1,931 | 1,617 |
Other Revenue | - | 2.59 | 7.81 | 2.04 | 8.2 |
| 1,861 | 2,014 | 1,681 | 1,933 | 1,625 | |
Revenue Growth (YoY) | -7.58% | 19.79% | -13.06% | 18.98% | 3.63% |
Cost of Revenue | 1,666 | 1,854 | 1,599 | 1,572 | 1,264 |
Gross Profit | 194.72 | 159.99 | 81.95 | 361.73 | 361.29 |
Selling, General & Admin | 220.68 | 176.37 | 192.63 | 159.9 | 151.37 |
Research & Development | 78.82 | 85.7 | 98.48 | 103.91 | 73.63 |
Other Operating Expenses | 5.68 | 10.46 | 8.98 | 9.15 | 7.14 |
Operating Expenses | 305.19 | 273.68 | 300.85 | 274.84 | 234.01 |
Operating Income | -110.47 | -113.69 | -218.9 | 86.89 | 127.28 |
Interest Expense | - | -40.19 | -32.19 | -25.44 | -22.78 |
Interest & Investment Income | 0.02 | 5.36 | 5.34 | 6.3 | 5.05 |
Currency Exchange Gain (Loss) | - | 10.93 | 7.34 | 4.5 | -1.23 |
Other Non Operating Income (Expenses) | -41.13 | -4.85 | -4.16 | -3.37 | -2.76 |
EBT Excluding Unusual Items | -151.58 | -142.43 | -242.58 | 68.88 | 105.56 |
Gain (Loss) on Sale of Investments | - | -0.01 | -2.05 | -2.19 | - |
Gain (Loss) on Sale of Assets | -0.72 | -0.72 | -0.09 | 0.63 | -1.77 |
Asset Writedown | -9.28 | - | - | -0.5 | -0.3 |
Other Unusual Items | - | 6.96 | 8.12 | 4.21 | 5.41 |
Pretax Income | -161.59 | -136.2 | -236.6 | 71.03 | 108.9 |
Income Tax Expense | -24.98 | -13.75 | -44.12 | -2.1 | 10.31 |
Net Income | -136.61 | -122.45 | -192.47 | 73.14 | 98.59 |
Net Income to Common | -136.61 | -122.45 | -192.47 | 73.14 | 98.59 |
Net Income Growth | - | - | - | -25.82% | -4.76% |
Shares Outstanding (Basic) | 142 | 142 | 143 | 143 | 133 |
Shares Outstanding (Diluted) | 142 | 142 | 143 | 143 | 133 |
Shares Change (YoY) | -0.06% | -0.13% | -0.58% | 7.63% | 24.73% |
EPS (Basic) | -0.96 | -0.86 | -1.35 | 0.51 | 0.74 |
EPS (Diluted) | -0.96 | -0.86 | -1.35 | 0.51 | 0.74 |
EPS Growth | - | - | - | -31.08% | -23.65% |
Free Cash Flow | -115.64 | -69.81 | -48.03 | -169.54 | -190.49 |
Free Cash Flow Per Share | -0.81 | -0.49 | -0.34 | -1.18 | -1.43 |
Dividend Per Share | - | - | - | 0.100 | 0.154 |
Dividend Growth | - | - | - | -34.98% | - |
Gross Margin | 10.46% | 7.95% | 4.88% | 18.71% | 22.23% |
Operating Margin | -5.94% | -5.65% | -13.02% | 4.49% | 7.83% |
Profit Margin | -7.34% | -6.08% | -11.45% | 3.78% | 6.07% |
Free Cash Flow Margin | -6.21% | -3.47% | -2.86% | -8.77% | -11.72% |
EBITDA | 107.86 | 61.7 | -54.02 | 239.01 | 241.32 |
EBITDA Margin | 5.80% | 3.06% | -3.21% | 12.36% | 14.85% |
D&A For EBITDA | 218.33 | 175.39 | 164.87 | 152.12 | 114.04 |
EBIT | -110.47 | -113.69 | -218.9 | 86.89 | 127.28 |
EBIT Margin | -5.94% | -5.65% | -13.02% | 4.49% | 7.83% |
Effective Tax Rate | - | - | - | - | 9.46% |
Revenue as Reported | - | 2,014 | 1,681 | 1,933 | 1,625 |
Advertising Expenses | - | 1.67 | 1.73 | 0.77 | 1.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.